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Abstract 
Several D-ribonucleosides are prepared from1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranoside and 
trimethylsilylated nucleobases under mild conditions by using natural phosphate doped with I2 as catalyst      
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Introduction 
For a few decades, sugar-modified nucleosides have provided important leads.The nucleoside analogues have a 
game biological activity cover all the large axes with chemotherapy to knowing, activity cardiovascular (Stein 
and al 1975), antiviral (Bolch and al 1974), pesticide (Hoffman and al 1976), antibiotic (Suhadolkin and al 1970) 
and anti-cancer (Burchenal and al 1975) considering their importance and their place primarily in chemotherapy. 
For example, thiazofurin is a C-nucleoside which has been shown to inhibit the inosine 5’-monophosphate 
dehydrogenase (IMPDH), thus inducing a shutdown of the guanine nucleotide synthesis and causing the 
apoptosis of human erythroleukemia cells. Ribavirin, a synthetic nucleoside, in combination with the pegylated . 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Structure of some potent five-membered ring nucleosides. 
The solid-liquid heterogeneous synthesis in is studied more the most, the advantages of this new method are : 
The reactions proceed under conditions simplicity and oft, the products obtained clean and are easily separated 
from the relational medium. Many reagents solids were used in these reactions alumina (Lam and al 1974), 
Celite (Khan and al 1975), silica (Hudlicky and al 1974), zeolite (Clark and al 2002), this last have the 
advantages such as: non-toxicity and experimental simplicity (Zahouily and al 2004).The nucleoside analogues 
are synthesized by using rock phosphate doped by KI in the HMDS in the reaction of glycosylation ((a)Taourirt 
and al 2005) (b)Lazrek and al 2006)(c)Lazrek and al 2007)(d) Lazrek and al 2008) (e) Baddi and al 2010)(f) 
Lazrek  and al 2011)). Recently, various types of inorganic synthesis. Natural phosphate (NP) is an important 
mining wealth of Morocco. Many investigations were performed in our laboratory to valorise the use of (NP) in 
heterogeneous catalysis (Alahiane and al 2003).In this respect, and in connection with our other work on the use 
of natural phosphate as a catalyst (Rochdi and al 2003), According to literature, several reactions were carried 
out by using iodine (I2) like catalyst in the HMDS (Karimi and al 2000) .we now report a new one pot novel 
method using as a catalyst inexpensive natural phosphate doped with I2 instead of TMSOTf, TMSClO4, SnCL4, 
or (CH3)3SiI to perform the glycosylation reaction (scheme1 ).  
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Table 1: Synthesis of 2’, 3, 5’-tri-O-benzoyl-α/β-D-ribonucleosides 
Entry Nucleobase NP/I2 Yield% α/β 
1 Uracil 325/0 5 …… 
2 Uracil NP/I2 (1eq of I2 ) 40 33/67 
3 Uracil NP/I2 (0.5eq of I2) 47 50/50 
4 Uracil NP/I2 (0.2eq of I2 ) 62 22/78 
5 Uracil Silice / I2  (0.2eq of I2 ) 55 20/80 
6 Uracil Al2O3 / I2(0.2eq of I2 ) 48 20/80 
7 Thymine NP/I2 (0.2eq of I2 ) 55 10/90 
8 Cytosine NP/I2 (0.2eq of I2 ) 52 10/90 
9 Adenine NP/I2 (0.2eq of I2 ) 55 15/85 
10 N-DMF-guanine NP/I2 (0.2eq of I2 ) 35 50/50 
 
Results and discussion  
As shown in Table1,when either NP were used alone, the reaction of 1-O-acetyl-2,3,5-tri-O- benzoyl-β-D-  
ribofuranoside with bis-(trimethylsilyl)uracil gave the ribonucleoside in only 5 % .As can be seen in the 
subsequent examples, the yield increased when NP doped with I2 was used. For example, in entry 2,3,4  the 
desired ribonucleoside was obtained as a major isomer and in good yield (62%) by using NP/I2 corresponding to 
0.2 eq of I2.in acetonitrile at 1050 C overnight. To study the difference between different the  solid catalysts ,the 
silica doped with lode (entry5) and the alumina  doped with lode (entry 6)are used in glycosylation and give 
55% ,48 % yield respectively, According to the experiment this shows that the natural phosphate is more 
effective thane other solids catalyst.This procedure appears to other nucleobases(entries 7-10).were then also 
subjected toN-glycosylation and found to afford the corresponding nucleosides in 55%, 52%, 55%, 35% yields 
respectively.This reaction is sterioselective and give one isomer N-1 for 
pyrimidine(Uracil,Thymine,cytosine)and the N-9 for purine (Adenine,Nac–Guanine).*The reaction seems to 
occur via the substitution of the acetoxy group on the anomeric carbon with iodide in the first step, and TMSI is 
generated during the condensation step with silylated base. The mechanism of the above glycosylation could be 
depicted as follows (Scheme2): silylated uracil may react with NP/KI to give (CH3)3-Si-I.The later will reac with 
1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose to afford 1-Iodo-2,3,5-tri-O-benzoyl-α,β-D-ribofuranose 
Further, the complex [heterocycle]-/[NP-I]+ will react with iodo sugar to conduct to the desired nucleosides with 
the anomerie (α,β).It is well know that Lewis acid activate the anomeric center in peracylated furanose and 
pyranose sugar leading to the formation of a glycosidic linkage having the 1,2-trans configuration.The high 
selectivity in the glycosylation reactions using Lewis Acid (SnCl4,TMSOTf..)is attributed to the neighbouring 
group effect of the C-2 substituent via formation of an acyloxonium ion with concomitant stabilisation of the 
positive charge on C-1.This also results in effective blockage of one face leads to1,2-trans glycosylation.We 
carried out reaction under the same conditions as above.The exclusive formation of α,β-anomer is aproof  that 
the intermediate is theIodo-2,3,5-tri-O-benzoyl-α,β-D-ribofuranos.  
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Scheme2. Standard Vorbru1ggen Glycosylation Reaction Conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
In summary, we describe a simple, efficient, and eco-friendly method for the synthesisof D-ribonucleosides 
using cheap and readily available catalyst ( NP/I2). This methodology is an additive method to the conventional, 
but makes it significant under the umbrella of environmentally greener and safer processes. 
Experimental Section 
Preparation of NP doped with I2 (PN/I2) 4/1  
759mg of I2 and 5ml of methanol chloride was putted in a flake, after 3min of stirring 3g of Natural phosphate 
(NP) was added, after the mixture was evaporated. 
Typical procedure for one –pot synthesis  
To uracil (112 mg,1 mmol) was added hexamethyldisilazane (HMDS) (4mL) and ammonium sulphate           (10 
mg).The mixture was refluxed for two hours.To the obtained clear solution was added 1-O-acetyl-2,3,5-tri-O-
benzoyl-β-D-ribofuranose (453mg,0.9mmol),NP/I2 (473mg)and acetonitrile(5mL). After being refluxed 
overnight,the mixture was filtered and the solvent evaporated. The crude product was purified by column 
chromatography.The desired product was obtained with 62% yield 
General Remarks 
The NMR spectra were recorded on a Bruker AC 300 MHz spectrometers. Chemical shifts were reported in 
scale (ppm) relative to TMS as a standard and the coupling constants J values are given in Hz. EI mass spectra 
were recorded on a Varian MAT 311A spectrometer. TLC was performed on 60 F254 precoated plastic plates 
silica gel (Merck). Column chromatography was performed on silica gel. (Baker, 30-60 µm). All solvents were 
distilled and dried before using. 
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►2’, 3’, 5’-Tri-O-benzoyl- α, β- D-uridine 4 
1
H NMR(CDCl3) (300MHz) ) δ(ppm) 4 .40(m, 2H, H’5) ; 4.90(m,1H, H’4) ;5.55( d, 1H, H5, J= 6Hz) ; 
5.65(pseudot,1H, H’3) ; 5.80( pseudo t, 1H, H’2) ; 6.30(d, 1H, H’1β J=5.4Hz) ; 6.35( d, 1H, H’1α, J=3,6 Hz) ; 
7.39 (d, 1H, H6, J=6Hz) ; 7.40-8.10(m,15H, Harom Bz) ;10.40(S, 1H, N-H).   
13
C NMR (CDCl3) δ(ppm) ; 63.73 (C5’) ; 71.40 (C4’) ; 75.10(C3’) ; 80(C2’) ;86 (C1’α) ; 88(C1’β) ; 100.59 (C5); 
128.43-135.70 (Ph) ; 145.09 (C6); 150.33 (C4)162,90 (C2) 165.05-169.11 (PhCO)   
►2’, 3’, 5’-Tri-O-benzoyl- α ,β-D-thymidine  7 
1
H NMR(CDCl3) (300MHz)δ(ppm) ;1.95(s,3H, CH3) ;4.40(m, 2H, H’5) ;4.90(m,1H, H’4) ;5,5( pseudo t, 1H, 
H’3) ; 5.8( pseudot , 1H, H’2) ; 6.40(d, 1H, H’1β J=3.6 Hz) ;6.45( d, 1H, H’1α, J=6,3 Hz); 7.39 (s, 1H, H6) ; 
7.40-8.10(m,15H, Harom Bz) ; 9.80(s,1H, NH).  
13
CNMR(CDCl3)δ(ppm) ;12.17(CH3) ;63.40(C5’),71.38(C4’),75.09(C3’),79.99(C2’) ;85(C1’α);87 
(C1’β) ;109.89(C5);128.43-132.70(Ph) ;142.07(C6);151.30(C4);164.62(C2) ;165.05 168.77(PhCO) . 
►2’, 3’, 5’-  Tri-O-benzoyl- α , β- D-cytidine 8 
1
H NMR(CDCl3) (300MHz)δ(ppm) 8,40(S, 2H, NH2) 1.95(s, 3H, CH3) 7.28 (d, 1H, H6, J=7.5 Hz)  5.50(d, 1H, 
H5,J=7.5Hz)6.20( d, 1H, H’1α, J=3.6 Hz) 6.10(d, 1H, H’1β J=7.2 Hz). 5.95 ( pseudot, 1H, H’2) 5.90( pseudo t, 
1H, H’3)4.90(m, 1H, H’4) 4.40(m, 2H, H’5) 7.40-8.10(m,15H, Harom Bz)  
13
C (CDCl3) (300MHz)  δ(ppm), 88 (C1’α) ; 91(C1’β), 63.65(C5’), 70.90(C4’), 75.09(C3’), 80.01(C2’), 128.43-
133(Ph) ,165.05- 168 ( PhCO), 97.33( C5); 144.56 (C6),145.60 ( C4); 163.23( C2) 
►2’, 3’, 5’-Tri-O-benzoyl-α ,β-D-adenosine 9 
1
H NMR(CDCl3) (300MHz)δ(ppm) 8.20(s, 1H, H2) 8.15 (s, 1H, H8) 6.30(m, 2H, NH2). 
6.47(s, 1H, H’1α) 6.45(d, 1H, H’1β J=5 Hz) .5.95(pseudo t, 1H, H’2) 4.90( pseudo t, 1H, H’3)4.80(m, 1H,H’4) 
4.70(m, 2H, H’5) 7.40-8.10(m,15H, Harom Bz)  
13
C(CDCl3)(300MHz)δ(ppm),85(C1’α) ;87(C1’β),63.38(C5’),71.34(C4’),73.77(C3’),80.66(C2’),128.43-
133(Ph),165.05-168(PhCO),119.26(C5);141.77(C6);150.28(C4);153.02(C2);155.29( C8). 
►N-dimethylformamide-2’, 3’, 5’-Tri-O-benzoyl- α ,β- D-guanosine 10 
1
H NMR(CDCl3) (300MHz)δ(ppm) 3.37 (s,6H, 2CH3 )8.40 (s, 1H, H8) 8.1 (s, 1H,CH,) 6.31(s, 1H, H’1α) 6.29(s, 
1H, H’1β ) .6.36(pseudo t, 1H, H’2) 6.19( pseudo t, 1H, H’3)4.85(m, 1H, H’4) 4.871(m, 2H, H’5) 10.80(b, 1H, 
NH), 7.40-8.10(m,15H, Harom Bz)  
13
C(CDCl3)(300MHz)δ(ppm),86(C1’α),89(C1’β);64,95(C5’),71.88(C4’),80.17(C3’),80.37(C2’),129.46-
135.17(Ph),165-
166.63(PhCO).,166(CH3CO),41.27(CH3),41.54(CH3),137(CH)135.17(C5);137.27(C6);150.28(C4); 155.05(C2); 
157.82( C8). 
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